Cargando…
Pharmacological inhibition of ALCAT1 mitigates amyotrophic lateral sclerosis by attenuating SOD1 protein aggregation
OBJECTIVE: Mutations in the copper-zinc superoxide dismutase (SOD1) gene cause familial amyotrophic lateral sclerosis (ALS), a progressive fatal neuromuscular disease characterized by motor neurons death and severe skeletal muscle degeneration. However, there is no effective treatment for this debil...
Autores principales: | Liu, Xueling, Zhang, Jun, Li, Jie, Song, Chengjie, Shi, Yuguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287437/ https://www.ncbi.nlm.nih.gov/pubmed/35772643 http://dx.doi.org/10.1016/j.molmet.2022.101536 |
Ejemplares similares
-
SOD1 and Amyotrophic Lateral Sclerosis: Mutations and Oligomerization
por: Banci, Lucia, et al.
Publicado: (2008) -
Metal-deficient SOD1 in amyotrophic lateral sclerosis
por: Hilton, James B., et al.
Publicado: (2015) -
Cardiolipin remodeling by ALCAT1 links mitochondrial dysfunction to Parkinson’s diseases
por: Song, Chengjie, et al.
Publicado: (2019) -
Spinal cord homogenates from SOD1 familial amyotrophic lateral sclerosis induce SOD1 aggregation in living cells
por: Pokrishevsky, Edward, et al.
Publicado: (2017) -
Is SOD1 loss of function involved in amyotrophic lateral sclerosis?
por: Saccon, Rachele A., et al.
Publicado: (2013)